Hepatic cytochrome P-4503A (CYP3A) activity in the elderly

Area of Science:

• Pharmacology
• Geriatric Medicine
• Drug Metabolism

Background:

• Elderly individuals often experience reduced drug clearance due to decreased hepatic cytochrome P-450 (CYP450) activity.
• Cytochrome P-450 3A (CYP3A), a key enzyme in phase I drug metabolism, is inducible by glucocorticoids and metabolizes numerous drugs, including erythromycin.

Purpose of the Study:

• To investigate the activity of hepatic CYP3A in elderly males and females using the [14C]erythromycin breath test.
• To determine if gender-related differences in CYP3A activity persist in the elderly.
• To assess the influence of body weight, age, diet, and medication on CYP3A activity in geriatric volunteers.

Main Methods:

• Utilized the [14C]erythromycin breath test, a non-invasive method, to measure erythromycin N-demethylation in 24 healthy elderly volunteers (ages 70-88).
• Analyzed data for gender-related variations, effects of % ideal body weight, dietary fat intake, age, and medication use.
• Employed multivariable linear regression to evaluate the impact of various factors on CYP3A activity.

Main Results:

• CYP3A activity, measured by [14C]erythromycin N-demethylation, exhibited significant gender dimorphism in the elderly, with females showing higher activity (3.14%) than males (2.15%).
• Increased % ideal body weight was significantly associated with decreased CYP3A activity (P = 0.001), independent of gender.
• CYP3A activity in elderly volunteers was comparable to younger subjects and was not significantly affected by dietary fat intake.

Conclusions:

• Gender-related heterogeneity in human hepatic glucocorticoid-inducible CYP3A function persists throughout normal aging.
• CYP3A activity may decrease in obesity, suggesting a potential impact on drug metabolism in heavier elderly individuals.
• The activity of CYP3A appears to be stable across the spectrum of normal aging in healthy individuals.